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Abstract. Perianal fistula usually results from a non-specific infection of the cryptic glands located at the anal dentate line. 
Identification of the exact course of a perianal fistula and the extent of anal sphincteric complex involvement are of 
paramount importance, in order to design the therapeutic and interventional approach and achieve the best results without 
impairment of the anorectal function. Several interventional methods are in use for the surgical treatment of CPF, including 
fistulotomy, insertion of cutting “seton”, core fistulectomy, ligation of the intersphincteric fistulous track (LIFT), rectal 
advancement flap, injection of fibrin glue at the fistulous track, insertion of fistulous plug, and obliteration of the fistulous 
track with the use of Laser. In clinical practice a combination of the aforementioned methods can be used, in particular for 
the complex-high or recurrent fistulae. 




Perianal fistula usually results from a non-specific infection 
of the cryptic glands located at the anal dentate line. Other 
less common causes are infection from unusual bacteria, 
inflammatory bowel disease – mostly Crohn’s, malig-
nancy, trauma and radiation of the perianal area [14]. 
According to the course through the anal and perineal 
musculature to their origin at the dentate line, Parks et al. 
[5] classified perianal fistulas as subcutaneous-superficial, 
intersphincteric (coursing between internal and external 
sphincter), transphincteric (coursing through the external 
sphincter and internal sphincters), suprasphincteric (cours-
ing over the puborectalis) and extrasphincteric, the latter 
usually different to cryptoglandular sepsis etiology. More 
recently, perianal fistulae are classified as low (involve-
ment of the distal third of the sphincteric complex) and 
high (involvement of the middle or/and the upper third of 
the sphincteric complex) (Fig. 1). In addition, low and high 
perianal fistulae are classified as simple and branching [6]. 
Diagnostic Methods 
Identification of the exact course of a perianal fistula and 
the extent of anal sphincteric complex involvement are of 
paramount importance, in order to design the therapeutic 
and interventional approach and achieve the best results 
without impairment of the anorectal function. Magnetic 
resonance imaging (MRI) is considered the gold standard 
diagnostic tool for the assessment of cryptoglandular 
perianal fistulae (CPF), in particular the high ones, with 
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accuracy rates above 90% [710]. Also, valuable infor-
mation for high, complex and recurrent CPF can be ob-
tained with the use of three-dimensional endosonography. 
Accuracy rate of this modality ranges from 50% to 100%, 
depending on the examiner’s expertise [1015]. Combi-
nation of both modalities increases accuracy [10].   
 
Fig. 1 Diagrammatic representation of the Park’s 
classification of perianal fistula. S: sabcutaneous-
superficial; 1: intersphincteric; 2: transsphincteric; 
3: suprasphincteric; 4: extrasphincteric [5]. 
Treatment 
Several interventional methods are in use for the surgi-
cal treatment of CPF, including fistulotomy [1618], 
insertion of cutting “seton” [1921] or loose “seton” 
[2123], core fistulectomy [24], ligation of the in-
tersphincteric fistulous track (LIFT) [25], rectal ad-
vancement flap [2630], injection of fibrin glue at the 
fistulous track [23,31,32], insertion of fistulous plug 
[33,34], and obliteration of the fistulous track with the 
use of Laser [3537]. In clinical practice a combination 
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of the aforementioned methods can be used, in particu-
lar for the complex-high or recurrent fistulae. 
Fistulotomy for the Low CPF 
Despite some discrepancies in the indications among 
several guidelines [10], fistulotomy (FT) is the most 
common method for the surgical treatment of CPF. The 
main indications of FT are the superficial-subcutaneous, 
intersphincteric and low transsphincteric (involving less 
than 30% of the anal sphincter complex) CRF [9,10, 
14,38]. Relative contraindications of FT for in-
tersphincteric and low transsphincteric CPF are i) pre-
operative impairment of continence, ii) multiparous fe-
male with marginal fecal continence, iii) previous sur-
gery, iv) recurrent CRF after fistulotomy, and v) Crohn’s 
disease. Absolute contraindications of FT as the sole 
treatment are high transsphincteric, suprasphincteric and 
extrasphincteric CPF [10,3941]. 
As regards the operative technique, under general 
anesthesia and the guidance of preoperative imaging 
assessment, i) the external opening is visualized, ii) the 
internal opening at the dentate line is identified with the 
injection of methylene blue through the external open-
ing, iii) any branching of the fistula is also sought and 
identified, iv) a probe is gently inserted from the exter-
nal opening, through the fistulous track to the internal 
opening at the dentate line, and v) the FT is carried out 
in a lay-open fashion with the use of a scalpel or elec-
trocautery.   
FT for the simple and low CPF is associated with 
high success rate, ranging from 80% to 100%, at the 
immediate follow-up [4144]. Garces-Albir et al [13] 
report no recurrence after FT for simple and low CPF at 
one-year postoperatively, provided the extent of fistu-
lotomy had been quantified preoperatively with three-
dimensional endosonography. Cariati [45] reports 100% 
healing rate after FT for low CPF involving <10% of the 
distal external anal sphincter, at 6 months. Interestingly, 
van der Hagen et al [46] report that success rate of FT 
for low CRF decreases by time; from 93% at 12-month 
postoperatively to 74% and 61% at 48- and 72-month 
postoperatively. It is stated that recurrence can be either 
the result of treatment failure because of overlooked 
fistula branching or recurrent patient disease, as fistula 
recurrence occurs at different location in 54% of the 
cases. Patient predisposition may explain the latter ob-
servation, as it has been shown that there is an increased 
expression of pro-inflammatory cytokines and epithe-
lial-to-mesenchymal cell transition in CPF. Therefore, 
molecular mechanisms may also interfere in pathogene-
sis and also persistence of CPF [47].  
Some degree of incontinence, usually in the form of 
mucous discharge, is reported by more than 30% of the 
patients after FT [41,43,48]. Incontinence is minimal 
when FT is limited to the distal anal sphincter complex, 
and increases in parallel to the length of the external 
anal sphincter division [13]. Impairment of continence 
after FT is also related to preoperative functional status 
[41,43]. 
Complementary FT for High CPF 
FT may be part of the surgical treatment of high and 
complex CRF. Chatterjee et al [49] combined partial FT 
(from the external opening to the level of the dentate 
line) with cutting “seton” passing through the deep fis-
tulous track in 16 patients with high CPF. They ob-
served one recurrence and incontinence to flatus in one 
patient. A similar surgical approach was applied by 
Durgun et al [50] in 10 patients with high CPF, with no 
recurrence and only two patients complaining of incon-
tinence to flatus. 
Fung et al [51] performed partial FT of the subcuta-
neous part of the fistulous track and placed a loose seton 
through the fistulous track involving the sphincter complex 
in 46 patients with high CPF. They report a healing rate of 
86% and a recurrence rate of 19%, at a median follow-up 
of 42 months. Finally, Schultze and Ho [52], treated 75 
patients with high and complex CPF with a staged 
approach: at the first stage they performed FT involving 
the subcutaneous part of the fistulous track and placed a 
loose “seton” through the fistulous track involving the 
sphincter complex and, at the second stage four months 
later, they performed a LIFT procedure. They observed a 
recurrence rate of 12%, mostly attributed to incomplete 
identification and drainage of the fistulous track branching, 
and minor incontinence in one patient. 
Conclusions 
Prior to surgical intervention for the treatment of CPF, 
image identification of the fistulous track by MRI is 
mandatory. FT is the commonest procedure performed 
for the treatment of the low CPF, namely the subcutane-
ous, the intersphincteric and the low transsphincteric fis-
tula that involves less than 30% of the external sphincter 
mass. Relative contraindications of the procedure are 
Crohn’s disease and pre-existing impaired continence. 
Initial healing rate is very high, but there is a tendency of 
increased recurrence by time, as a result of either incom-
plete identification of fistulous track branching or pa-
tient’s predisposition. Incontinence after FT is of low 
incidence and minor severity. Partial FT can be combined 
with other techniques, such as “seton” placement or LIFT 
for the surgical treatment of the high transsphinteric, su-
prasphincteric and extrasphincteric fistulae. 
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